{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:54:29Z","timestamp":1774464869368,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shandong Provincial Natural Science Foundation of China","award":["ZR2021QH192"],"award-info":[{"award-number":["ZR2021QH192"]}]},{"name":"the Affiliated Hospital of Qingdao University Clinical Medical Research Program","award":["QDFYQN2023112"],"award-info":[{"award-number":["QDFYQN2023112"]}]},{"name":"Medical Health Research Project of Zibo","award":["20230204005"],"award-info":[{"award-number":["20230204005"]}]},{"name":"the QLMU research fund"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Nowadays, chronic pain remains a major clinical challenge because of the unsatisfactory efficacy and nonnegligible side effects of current treatments. Pharmacological antagonists of the transient receptor potential vanilloid-1 (TRPV1) channel for chronic pain relief have been confirmed in numerous preclinical studies. However, no TRPV1 antagonist has been approved in clinical, indicating an urgent need to develop effective TRPV1 antagonists with analgesic properties. In this study, we reported a TRPV1 antagonist 1-(1\n                    <jats:italic>H<\/jats:italic>\n                    -indazol-4-yl)-3-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methyl)urea named IMTU. According to the whole-cell patch clamp recording assay, we identified that IMTU was a potent and selective TRPV1 antagonist with an IC\n                    <jats:sub>50<\/jats:sub>\n                    value of 128.34\u2009\u00b1\u20099.49 nM and exciting no inhibition of cardiotoxicity-related channels. Further single-channel recording assay revealed that IMTU (300 nM) reduced the channel open probability from 80.8\u2009\u00b1\u20092.1% to 14.9\u2009\u00b1\u20092.8% with the presence of capsaicin (100 nM). In addition, does-dependent administration of oral IMTU alleviated nociceptive reactions on mouse models of formalin and inflammatory pain induced by complete Freund\u2019s adjuvant (CFA) without hyperthermia. Finally, studies on molecular docking combined with site-directed mutagenesis suggested that residue Thr550 was critical for the TRPV1 antagonist by IMTU. Taken together, we identified a novel and selective TRPV1 antagonist IMTU exhibiting analgesic properties in mice, which provide a useful lead for the development of analgesia in the future.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0345127","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:33:43Z","timestamp":1774460023000},"page":"e0345127","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2608-2449","authenticated-orcid":true,"given":"Jialiang","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7596-4723","authenticated-orcid":true,"given":"Chao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"1","key":"pone.0345127.ref001","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1152\/physrev.00023.2013","article-title":"Calcium-permeable ion channels in pain signaling","volume":"94","author":"E Bourinet","year":"2014","journal-title":"Physiol Rev"},{"issue":"3","key":"pone.0345127.ref002","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1213\/ANE.0000000000001389","article-title":"A systematic review and meta-analysis of the global burden of chronic pain without clear etiology in low- and middle-income countries: Trends in heterogeneous data and a proposal for new assessment methods","volume":"123","author":"T Jackson","year":"2016","journal-title":"Anesthesia and Analgesia"},{"issue":"10","key":"pone.0345127.ref003","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jpain.2008.05.005","article-title":"Common chronic pain conditions in developed and developing countries: Gender and age differences and comorbidity with depression-anxiety disorders","volume":"9","author":"A Tsang","year":"2008","journal-title":"J Pain"},{"issue":"10289","key":"pone.0345127.ref004","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: An update on burden, best practices, and new advances","volume":"397","author":"SP Cohen","year":"2021","journal-title":"Lancet"},{"issue":"6653","key":"pone.0345127.ref005","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: A heat-activated ion channel in the pain pathway","volume":"389","author":"MJ Caterina","year":"1997","journal-title":"Nature"},{"key":"pone.0345127.ref006","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1038\/ncomms9297","article-title":"A pain-inducing centipede toxin targets the heat activation machinery of nociceptor TRPV1","volume":"6","author":"S Yang","year":"2015","journal-title":"Nat Commun"},{"issue":"3","key":"pone.0345127.ref007","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1085\/jgp.200709731","article-title":"Thermosensitive TRPV channel subunits coassemble into heteromeric channels with intermediate conductance and gating properties","volume":"129","author":"W Cheng","year":"2007","journal-title":"J Gen Physiol"},{"issue":"24","key":"pone.0345127.ref008","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1016\/j.febslet.2006.09.030","article-title":"Jellyfish and other cnidarian envenomations cause pain by affecting TRPV1 channels","volume":"580","author":"E Cuypers","year":"2006","journal-title":"FEBS Lett"},{"key":"pone.0345127.ref009","doi-asserted-by":"crossref","first-page":"109178","DOI":"10.1016\/j.cbi.2020.109178","article-title":"Modulation of TRPV1 channel function by natural products in the treatment of pain","volume":"330","author":"MA Abbas","year":"2020","journal-title":"Chem Biol Interact"},{"issue":"8","key":"pone.0345127.ref010","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/bph.12092","article-title":"The contribution of the endogenous TRPV1 ligands 9-HODE and 13-HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms","volume":"168","author":"M Alsalem","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"3","key":"pone.0345127.ref011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/WNR.0000000000000322","article-title":"The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice","volume":"26","author":"M Watanabe","year":"2015","journal-title":"Neuroreport"},{"issue":"1","key":"pone.0345127.ref012","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40265-020-01429-2","article-title":"TRPV1-targeted drugs in development for human pain conditions","volume":"81","author":"M Iftinca","year":"2021","journal-title":"Drugs"},{"issue":"17","key":"pone.0345127.ref013","article-title":"IL-23\/IL-17A\/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice","volume":"109","author":"X Luo","year":"2021","journal-title":"Neuron"},{"issue":"11","key":"pone.0345127.ref014","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1016\/j.bmcl.2010.04.047","article-title":"Discovery of TRPV1 antagonist ABT-116","volume":"20","author":"BS Brown","year":"2010","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"pone.0345127.ref015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2011.05.001","article-title":"Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl) -amine (JNJ-39729209) as a novel TRPV1 antagonist","volume":"663","author":"MP Maher","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"pone.0345127.ref016","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","article-title":"Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans","volume":"136","author":"NR Gavva","year":"2008","journal-title":"Pain"},{"key":"pone.0345127.ref017","doi-asserted-by":"crossref","first-page":"107474","DOI":"10.1016\/j.pharmthera.2020.107474","article-title":"Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis","volume":"208","author":"A Garami","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"1","key":"pone.0345127.ref018","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.107.125674","article-title":"Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade","volume":"323","author":"NR Gavva","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"pone.0345127.ref019","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-2036.2011.04629.x","article-title":"Randomised clinical trial: The efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain","volume":"33","author":"AL Krarup","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"pone.0345127.ref020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cct.2013.12.007","article-title":"Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis","volume":"37","author":"F Miller","year":"2014","journal-title":"Contemp Clin Trials"},{"issue":"7607","key":"pone.0345127.ref021","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature17964","article-title":"TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action","volume":"534","author":"Y Gao","year":"2016","journal-title":"Nature"},{"issue":"7478","key":"pone.0345127.ref022","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature12822","article-title":"Structure of the TRPV1 ion channel determined by electron cryo-microscopy","volume":"504","author":"M Liao","year":"2013","journal-title":"Nature"},{"issue":"17","key":"pone.0345127.ref023","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.3390\/molecules27175428","article-title":"Identification of a Partial and Selective TRPV1 Agonist CPIPC for Alleviation of Inflammatory Pain","volume":"27","author":"L Dong","year":"2022","journal-title":"Molecules"},{"issue":"17","key":"pone.0345127.ref024","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1021\/acs.jmedchem.2c00469","article-title":"Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with analgesic effects in vivo based on the functional conversion induced by altering the orientation of the indazole core","volume":"65","author":"Q Liang","year":"2022","journal-title":"J Med Chem"},{"issue":"7","key":"pone.0345127.ref025","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/bph.15390","article-title":"A plant-derived TRPV3 inhibitor suppresses pain and itch","volume":"178","author":"Y Han","year":"2021","journal-title":"Br J Pharmacol"},{"key":"pone.0345127.ref026","article-title":"Cell-based calcium assay for medium to high throughput screening of TRP channel functions using FlexStation 3","volume":"54","author":"J Luo","year":"2011","journal-title":"J Vis Exp"},{"issue":"3","key":"pone.0345127.ref027","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/j.pain.0000000000001450","article-title":"Islet-cell autoantigen 69 mediates the antihyperalgesic effects of electroacupuncture on inflammatory pain by regulating spinal glutamate receptor subunit 2 phosphorylation through protein interacting with C-kinase 1 in mice","volume":"160","author":"K Han","year":"2019","journal-title":"Pain"},{"issue":"7478","key":"pone.0345127.ref028","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature12823","article-title":"TRPV1 structures in distinct conformations reveal activation mechanisms","volume":"504","author":"E Cao","year":"2013","journal-title":"Nature"},{"key":"pone.0345127.ref029","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tox.2011.10.009","article-title":"Ionic mechanisms underlying cardiac toxicity of the organochloride solvent trichloromethane","volume":"290","author":"Y Zhou","year":"2011","journal-title":"Toxicology"},{"key":"pone.0345127.ref030","doi-asserted-by":"crossref","first-page":"117750","DOI":"10.1016\/j.bmc.2024.117750","article-title":"Discovery of first-in-class highly selective TRPV1 antagonists with dual analgesic and hypoglycemic effects","volume":"107","author":"C Liu","year":"2024","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"pone.0345127.ref031","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/13543776.2015.1008449","article-title":"Transient receptor potential vanilloid type 1 antagonists: A patent review (2011 - 2014)","volume":"25","author":"Y Lee","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"pone.0345127.ref032","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.2147\/JPR.S217439","article-title":"Effects of an intrathecal TRPV1 antagonist, SB366791, on morphine-induced itch, body temperature, and antinociception in mice","volume":"12","author":"S Sakakibara","year":"2019","journal-title":"J Pain Res"},{"issue":"2","key":"pone.0345127.ref033","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/cells3020517","article-title":"TRPV1: A potential drug target for treating various diseases","volume":"3","author":"R Brito","year":"2014","journal-title":"Cells"},{"issue":"4","key":"pone.0345127.ref034","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1152\/physrev.00026.2005","article-title":"Neuronal control of skin function: The skin as a neuroimmunoendocrine organ","volume":"86","author":"D Roosterman","year":"2006","journal-title":"Physiol Rev"},{"issue":"9","key":"pone.0345127.ref035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","article-title":"TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: Pro-inflammatory response induced by their activation and their sensitization","volume":"8","author":"O Gouin","year":"2017","journal-title":"Protein Cell"},{"issue":"6840","key":"pone.0345127.ref036","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/35082088","article-title":"Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition","volume":"411","author":"HH Chuang","year":"2001","journal-title":"Nature"},{"issue":"8","key":"pone.0345127.ref037","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbadis.2007.01.008","article-title":"TRP channels: targets for the relief of pain","volume":"1772","author":"JD Levine","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"pone.0345127.ref038","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-cellbio-101011-155833","article-title":"TRP channels and pain","volume":"29","author":"D Julius","year":"2013","journal-title":"Annu Rev Cell Dev Biol"},{"key":"pone.0345127.ref039","doi-asserted-by":"crossref","first-page":"113736","DOI":"10.1016\/j.jep.2020.113736","article-title":"Active components of Bupleurum chinense and Angelica biserrata showed analgesic effects in formalin induced pain by acting on Nav1.7","volume":"269","author":"Y Xu","year":"2021","journal-title":"J Ethnopharmacol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:33:50Z","timestamp":1774460030000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0345127"}},"subtitle":[],"editor":[{"given":"Alexander G","family":"Obukhov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0345127","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}